Neurocrine Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	428	341.3	249.7	154.5	89.6	407.3
Depreciation & Amortization	29.7	27.1	21.3	15.6	10.9	8.6
Other Amortization	-	-	-	-	17.3	21.4
Loss (Gain) From Sale of Investments	-7.7	10.9	-46.7	-27.1	-13.5	17.7
Stock-Based Compensation	225.7	195.5	194.3	173.1	134.2	100
Other Operating Activities	128.1	39.8	-56.9	90.7	1.3	-288.6
Change in Accounts Receivable	-246.9	-39.8	-89.3	-162.2	-28.4	-30.5
Change in Inventory	-23.5	-19.1	5.4	-2.6	-2.5	-10.7
Change in Accounts Payable	146.6	29	64.3	114.6	56.8	26.9
Change in Other Net Operating Assets	19.6	10.7	47.8	-17.2	-9.2	-23.6
Operating Cash Flow	636.8	595.4	389.9	339.4	256.5	228.5
Operating Cash Flow Growth	33.67%	52.71%	14.88%	32.32%	12.25%	55.44%
Capital Expenditures	-43.7	-38.2	-28.3	-16.5	-23.4	-10.9
Cash Acquisitions	-	-	-	-42.7	-	-
Investment in Securities	-236.1	-88.6	-438.8	-117.9	-106.8	15
Investing Cash Flow	-279.8	-126.8	-467.1	-177.1	-130.2	4.1
Long-Term Debt Repaid	-	-308.8	-	-279	-0.1	-186.9
Net Debt Issued (Repaid)	-	-308.8	-	-279	-0.1	-186.9
Issuance of Common Stock	102.1	122.1	65.3	44.7	27.5	29.1
Repurchase of Common Stock	-467.7	-300	-	-	-	-
Financing Cash Flow	-365.6	-486.7	65.3	-234.3	27.4	-157.8
Foreign Exchange Rate Adjustments	-0.3	-	0.3	-1.3	-	-
Net Cash Flow	-8.9	-18.1	-11.6	-73.3	153.7	74.8
Free Cash Flow	593.1	557.2	361.6	322.9	233.1	217.6
Free Cash Flow Growth	34.77%	54.09%	11.98%	38.52%	7.12%	64.48%
Free Cash Flow Margin	22.11%	23.66%	19.16%	21.69%	20.57%	20.80%
Free Cash Flow Per Share	5.80	5.37	3.58	3.27	2.38	2.23
Cash Interest Paid	-	1.6	3.8	6.6	8.6	11.6
Cash Income Tax Paid	146.6	217.5	51.5	14.4	5.1	15.3
Levered Free Cash Flow	346.19	457.98	439.25	247.63	265.75	278.59
Unlevered Free Cash Flow	346.19	457.98	439.25	247.63	264.58	277.69
Change in Working Capital	-153.7	-19.2	28.2	-67.4	16.7	-37.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.